Search results for "thrombus"

showing 10 items of 91 documents

Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins.

2006

The aim of this study was to evaluate different durations of treatment in patients with calf venous thrombosis (CVT) involving 1 or more deep veins. The authors studied 2 groups of patients with postsurgical CVT diagnosed by echo-color Doppler. The first group consisted of 68 patients with CVT involving a single vein, and the second group consisted of 124 patients with CVT involving 2 or more veins. Immediately after diagnosis, all patients were treated with nadroparin calcium and sodium warfarin. Heparin treatment was withdrawn after 5–6 days of treatment, when the international normalized ratio (INR) was stabilized between 2 and 3. Each group was divided into 2 subgroups receiving antico…

AdultMalemedicine.medical_specialtyFemoral vein030204 cardiovascular system & hematologyDrug Administration ScheduleLesion03 medical and health sciences0302 clinical medicinePostoperative ComplicationsMedicineHumans030212 general & internal medicineThrombusUltrasonography Doppler ColorVeinAgedVenous ThrombosisLegbusiness.industryAnticoagulantsNadroparinHeparinMiddle Agedmedicine.diseaseNadroparin calciumSurgeryVenous thrombosismedicine.anatomical_structureAnesthesiacardiovascular systemFemaleWarfarinmedicine.symptomCardiology and Cardiovascular MedicinebusinessSurgical patientsmedicine.drugAngiology
researchProduct

Detection of central pulmonary artery thromboemboli by transesophageal echocardiography in patients with severe pulmonary embolism.

1992

Transthoracic echocardiography generally provides only indirect signs of pulmonary embolism. In contrast, with transesophageal echocardiography the thromboembolus itself can be visualized in the central parts of the pulmonary artery. The aims of our study were to evaluate, first, the incidence of central pulmonary artery thromboemboli in patients with severe pulmonary embolism, and second, the accuracy of the echocardiographic diagnosis. Our study group comprised 60 patients with proved severe pulmonary embolism. All patients were examined by transthoracic and transesophageal echocardiography. The echocardiographic findings concerning the absence or presence of central pulmonary artery thro…

AdultMalemedicine.medical_specialtyHypertension PulmonaryBlood PressurePulmonary ArterySensitivity and SpecificityEsophagusInternal medicinemedicine.arteryThromboembolismmedicineHumansRadiology Nuclear Medicine and imagingIn patientProspective StudiesThrombusAgedbusiness.industryAngiography Digital SubtractionMiddle Agedmedicine.diseasePulmonary embolismEchocardiographyPulmonary arteryCardiologyFemaleRadiologyCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismTomography X-Ray ComputedJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
researchProduct

Thrombus-like small apical fibroma in patient with left ventricular dysfunction and thrombophilia: an unusual presentation.

2016

AdultMalemedicine.medical_specialtyPathologyMagnetic Resonance Imaging CineFibroma030204 cardiovascular system & hematologyThrombophiliacardiac magnetic resonanceHeart Neoplasms03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineCardiac fibromacardiac fibromacardiac maInternal medicinemedicineHumansThrombophiliaIn patientThrombusmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingThrombosisGeneral Medicinemedicine.diseaseThrombosisCardiac Imaging Techniques030220 oncology & carcinogenesisCardiologyFibromaPresentation (obstetrics)businessCardiology and Cardiovascular MedicineJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Sulodexide versus calcium heparin in the medium-term treatment of deep vein thrombosis of the lower limbs.

1997

Thirty adult patients with distal, monolateral deep vein thrombosis of the lower limbs were randomly treated for sixty days either with subcutaneous Ca-Heparin or with Sulodexide, administered IM for ten days and orally for fifty days. The thrombus accretion above the knee, the venous pressures of the affected leg, the clinical sympto matology, and some laboratory coagulative tests were monitored throughout the admin istration period. Local tolerability of the two treatments was also evaluated.The two applied treatments evidenced a net antithrombotic activity, preventing thrombus accretion above the knee, improving with the same efficacy the venous pressures in the affected legs, and simila…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.drug_classDeep vein030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsHumansMedicine030212 general & internal medicineThrombusAgedGlycosaminoglycansmedicine.diagnostic_testHeparinbusiness.industryAnticoagulantHeparinMiddle AgedThrombophlebitismedicine.diseaseThrombosisSulodexideSurgerymedicine.anatomical_structureTolerabilityAnesthesiaSettore BIO/14 - FarmacologiaFemaleAdult Aged Female Fibrinolytic Agents/administration & dosage Fibrinolytic Agents/therapeutic use* Glycosaminoglycans/administration & dosage Glycosaminoglycans/therapeutic use* Heparin/therapeutic use* Humans Male Middle Aged Thrombophlebitis/drug therapy*Cardiology and Cardiovascular Medicinebusinessmedicine.drugPartial thromboplastin time
researchProduct

Immediate versus delayed facilitated percutaneous coronary intervention. A pilot study

2005

The study was aimed to investigate the outcomes in patients initially successfully treated pharmacologically and immediate PCI <2 hours, and in patients initially successfully treated with pharmacological therapy and delayed PCI (12-72 hours). All patients had to have successful reperfusion, to receive the combination of a standard abciximab infusion plus half dose rtPA. Similar results were observed in both groups. Delayed PCI group showed a favorable trend in restenosis and bleedings (ns) and a significant reduced angiographic evidence of thrombus formation in IRA. Our very preliminary data suggest the safety and possible use of delayed facilitated PCI in patients with STEMI. The studied …

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentAbciximabMyocardial InfarctionMyocardial IschemiaEligibility DeterminationMyocardial ReperfusionPilot ProjectsAcute myocardial infarctionElectrocardiographyImmunoglobulin Fab FragmentsRestenosisInternal medicinemedicineAbciximabHumansIn patientcardiovascular diseasesThrombusAngioplasty Balloon CoronaryFacilitated pciDelayed percutaneous coronary interventionPharmacologybusiness.industryPatient SelectionPercutaneous coronary interventionAntibodies MonoclonalMiddle Agedmedicine.diseaseSurvival RateGIIb/IIIa inhibitorssurgical procedures operativeTreatment OutcomeTissue Plasminogen ActivatorConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinessFacilitated percutaneous coronary interventionTIMIPlatelet Aggregation InhibitorsCombined therapymedicine.drug
researchProduct

Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon-expandable Palmaz-Schatz …

1991

OBJECTIVE--Intracoronary stenting was designed to overcome acute complications after percutaneous transluminal coronary angioplasty and to achieve a reduced rate of restenosis, both of which are major limitations of this well accepted method for treating coronary heart disease. This report describes the experience at one centre with the implantation of balloon-expandable Palmaz-Schatz stents and focuses on device related complications and the short and long term angiographic outcome. DESIGN--A retrospective data analysis. PATIENTS--Stenting was attempted in 50 patients. Restenosis after an initially successful angioplasty procedure, inadequate postangioplasty results, saphenous coronary byp…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentArterial Occlusive DiseasesCoronary DiseaseBalloonCoronary AngiographyCoronary thrombosisRestenosisRecurrenceAngioplastymedicineHumansThrombusAngioplasty Balloon CoronaryAgedRetrospective Studiesbusiness.industryCoronary ThrombosisStentThrombolysisMiddle Agedmedicine.diseaseSurgeryBypass surgeryFemaleStentsRadiologyCardiology and Cardiovascular MedicinebusinessResearch Article
researchProduct

Nonocclusion and Early Reopening of the Great Saphenous Vein After Endovenous Laser Treatment Is Fluence Dependent

2004

Background. Parameters influencing failure and recanalization rates of endovenous laser treatment (ELT) of the great saphenous vein (GSV) are still to be determined. Objective. To evaluate treatment-related parameters of ELT with respect to early failure of occlusion or recanalization of GSVs. Methods. A series of 77 consecutive patients received ELT of 106 GSVs with continuous pullback of the laser fiber. Duplex examination was performed at 1 day, 4 weeks, and 3 months after the procedure. Clinical patient and vessel characteristics as well as technical parameters of the ELT procedure were evaluated via multiple logistic regression analysis. Results. A median vein length of 60 cm (range of…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentDermatologylaw.inventionRecurrenceRisk FactorslawOcclusionmedicineHumansSaphenous VeinThrombusAgedAged 80 and overCentimeterUnivariate analysisMedian Veinbusiness.industryGreat saphenous veinEndovenous laser treatmentGeneral MedicineMiddle Agedmedicine.diseaseLaserSurgeryLogistic ModelsLower ExtremityFemaleSurgeryLaser TherapyNuclear medicinebusinessDermatologic Surgery
researchProduct

Endovascular treatment as first choice in chronic intestinal ischemia.

2002

The purpose of this study was to define the place of endovascular treatment in chronic intestinal ischemia (CII). We report here a series of 19 consecutive patients treated with percutaneous angioplasty of the intestinal arteries. We excluded patients with acute ischemia, from the study. From January 1, 1989 to December 31, 2001, 19 patients with symptomatic CII were treated by endovascular techniques. This study group included 11 men and 8 women with a mean age of 59 years (range 30 to 90 years). The clinical presentation included postprandial pain in 16 patients, weight loss in 14 patients, with a mean weight loss of 7.4 kg (range 0 to 30 kg); and gastroparesis in 2 patients. Stenoses wer…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentInferior mesenteric arteryBlood Vessel Prosthesis ImplantationIntestinal arteriesPostoperative ComplicationsCeliac arteryIschemiaAngioplastymedicine.arteryInternal medicineMedicineHumansSuperior mesenteric arteryThrombusAgedUltrasonographyAged 80 and overbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseSurgeryIntestinesStenosismedicine.anatomical_structureTreatment OutcomeChronic DiseaseCardiologySurgeryFemaleStentsCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresArteryFollow-Up StudiesAnnals of vascular surgery
researchProduct

Paradoxical embolism through a patent foramen ovale from central venous catheter thrombosis: A potential cause of stroke

2020

Paradoxical embolism refers to a potential condition in which an embolus arising from a venous source crosses into the systemic circulation through a right-to-left cardiac shunt causing an arterial embolism. A 39-year-old woman carrier of a central venous catheter (CVC) without evident risk factors for stroke, developed an acute right homonymous hemianopia during hemodialysis. On neuroimaging, an infarct in the territory of the left posterior cerebral artery was demonstrated. Transesophageal echocardiography revealed a patent foramen ovale (PFO) and a large fluctuating thrombus in the right atrium on the tip of the CVC, thus allowing a diagnosis of ischemic stroke from paradoxical embolism.…

Adultmedicine.medical_specialtyArterial embolismCardioembolismmedicine.medical_treatmentEmbolismForamen Ovale Patent03 medical and health sciences0302 clinical medicineParadoxical embolismEmbolusUpper Extremity Deep Vein ThrombosisInternal medicinemedicineHumanscardiovascular diseases030212 general & internal medicineThrombusStrokebusiness.industryCardiac shuntmedicine.diseasePatent foramen ovaleStrokeNeurologyPatent foramen ovaleCardiologySettore MED/26 - NeurologiaFemaleNeurology (clinical)businessCentral venous catheterEchocardiography Transesophageal030217 neurology & neurosurgeryCentral venous catheterEmbolism ParadoxicalJournal of the Neurological Sciences
researchProduct

Magnetic resonance direct thrombus imaging for pre-operative assessment of acute thrombosis in chronic thromboembolic pulmonary hypertension

2018

Adultmedicine.medical_specialtyHypertension PulmonaryEndarterectomyPulmonary ArteryInternal medicinemedicineMedical imagingHumansThrombusThromboembolic pulmonary hypertensionmedicine.diagnostic_testbusiness.industryThrombosisMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingThrombosisPre operativeTreatment OutcomeChronic DiseasePreoperative PeriodCardiologyChronic thromboembolic pulmonary hypertensionAcute thrombosisPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct